Article info

Download PDFPDF
CASE REPORT
Brentuximab vedotin in combination with sequential procarbazine, cyclophosphamide and prednisolone for the management of Hodgkin’s lymphoma-associated vanishing bile duct syndrome (VBDS) with severe obstructive liver failure

Authors

  1. Correspondence to Dr Min Fong, m.fong{at}uq.edu.au
View Full Text

Citation

Fong M, Boyle S, Gutta N
Brentuximab vedotin in combination with sequential procarbazine, cyclophosphamide and prednisolone for the management of Hodgkin’s lymphoma-associated vanishing bile duct syndrome (VBDS) with severe obstructive liver failure

Publication history

  • Accepted February 9, 2019
  • First published February 21, 2019.
Online issue publication 
February 21, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.